Predictive Genetic Counselling Market Size to Hit USD 8.43 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Predictive Genetic Counselling Market

5.1. COVID-19 Landscape: Predictive Genetic Counselling Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Predictive Genetic Counselling Market, By Service Type

8.1. Predictive Genetic Counselling Market Revenue and Volume Forecast, by Service Type

8.1.1. Risk Assessment Counseling

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Predictive Testing & Counseling

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Reproductive & Family Planning Counseling

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Others

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Predictive Genetic Counselling Market, By Service Delivery Mode

9.1. Predictive Genetic Counselling Market Revenue and Volume Forecast, by Service Delivery Mode

9.1.1. In-Person Counseling

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Tele-Genetic Counseling

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Hybrid Counseling

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Predictive Genetic Counselling Market, By End-User

10.1. Predictive Genetic Counselling Market Revenue and Volume Forecast, by End-User

10.1.1. Hospitals

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Specialty Clinics (Oncology, Cardiology, Neurology, Etc.)

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Diagnostic & Genetic Testing Laboratories

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Academic & Research Institutions

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Others (Private Practices, Non-Profit Organizations)

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Predictive Genetic Counselling Market, By Application Area

11.1. Predictive Genetic Counselling Market Revenue and Volume Forecast, by Application Area

11.1.1. Oncology

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Cardiology

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Neurology

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Reproductive Health

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Rare & Metabolic Disorders

11.1.5.1. Market Revenue and Volume Forecast

11.1.6. Others (Preventive Wellness, Pediatrics)

11.1.6.1. Market Revenue and Volume Forecast

Chapter 12. Global Predictive Genetic Counselling Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Service Type

12.1.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.1.3. Market Revenue and Volume Forecast, by End-User

12.1.4. Market Revenue and Volume Forecast, by Application Area

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Service Type

12.1.5.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.1.5.3. Market Revenue and Volume Forecast, by End-User

12.1.5.4. Market Revenue and Volume Forecast, by Application Area

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Service Type

12.1.6.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.1.6.3. Market Revenue and Volume Forecast, by End-User

12.1.6.4. Market Revenue and Volume Forecast, by Application Area

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Service Type

12.2.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.2.3. Market Revenue and Volume Forecast, by End-User

12.2.4. Market Revenue and Volume Forecast, by Application Area

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Service Type

12.2.5.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.2.5.3. Market Revenue and Volume Forecast, by End-User

12.2.5.4. Market Revenue and Volume Forecast, by Application Area

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Service Type

12.2.6.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.2.6.3. Market Revenue and Volume Forecast, by End-User

12.2.6.4. Market Revenue and Volume Forecast, by Application Area

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Service Type

12.2.7.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.2.7.3. Market Revenue and Volume Forecast, by End-User

12.2.7.4. Market Revenue and Volume Forecast, by Application Area

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Service Type

12.2.8.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.2.8.3. Market Revenue and Volume Forecast, by End-User

12.2.8.4. Market Revenue and Volume Forecast, by Application Area

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Service Type

12.3.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.3.3. Market Revenue and Volume Forecast, by End-User

12.3.4. Market Revenue and Volume Forecast, by Application Area

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Service Type

12.3.5.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.3.5.3. Market Revenue and Volume Forecast, by End-User

12.3.5.4. Market Revenue and Volume Forecast, by Application Area

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Service Type

12.3.6.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.3.6.3. Market Revenue and Volume Forecast, by End-User

12.3.6.4. Market Revenue and Volume Forecast, by Application Area

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Service Type

12.3.7.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.3.7.3. Market Revenue and Volume Forecast, by End-User

12.3.7.4. Market Revenue and Volume Forecast, by Application Area

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Service Type

12.3.8.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.3.8.3. Market Revenue and Volume Forecast, by End-User

12.3.8.4. Market Revenue and Volume Forecast, by Application Area

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Service Type

12.4.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.4.3. Market Revenue and Volume Forecast, by End-User

12.4.4. Market Revenue and Volume Forecast, by Application Area

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Service Type

12.4.5.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.4.5.3. Market Revenue and Volume Forecast, by End-User

12.4.5.4. Market Revenue and Volume Forecast, by Application Area

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Service Type

12.4.6.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.4.6.3. Market Revenue and Volume Forecast, by End-User

12.4.6.4. Market Revenue and Volume Forecast, by Application Area

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Service Type

12.4.7.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.4.7.3. Market Revenue and Volume Forecast, by End-User

12.4.7.4. Market Revenue and Volume Forecast, by Application Area

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Service Type

12.4.8.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.4.8.3. Market Revenue and Volume Forecast, by End-User

12.4.8.4. Market Revenue and Volume Forecast, by Application Area

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Service Type

12.5.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.5.3. Market Revenue and Volume Forecast, by End-User

12.5.4. Market Revenue and Volume Forecast, by Application Area

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Service Type

12.5.5.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.5.5.3. Market Revenue and Volume Forecast, by End-User

12.5.5.4. Market Revenue and Volume Forecast, by Application Area

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Service Type

12.5.6.2. Market Revenue and Volume Forecast, by Service Delivery Mode

12.5.6.3. Market Revenue and Volume Forecast, by End-User

12.5.6.4. Market Revenue and Volume Forecast, by Application Area

Chapter 13. Company Profiles

13.1. Ambry Genetics

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performnace

13.1.4. Recent Initiatives

13.2. GeneDx (BioReference)

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performnace

13.2.4. Recent Initiatives

13.3. Genome Medical

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performnace

13.3.4. Recent Initiatives

13.4. 23andMe

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performnace

13.4.4. Recent Initiatives

13.5. PathGroup

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performnace

13.5.4. Recent Initiatives

13.6. MedGenome

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performnace

13.6.4. Recent Initiatives

13.7. Centogene AG

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performnace

13.7.4. Recent Initiatives

13.8. Veritas Genetics

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performnace

13.8.4. Recent Initiatives

13.9. Mapmygenome India,

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performnace

13.9.4. Recent Initiatives

13.10. Baylor Genetics

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial PerService Typeance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The predictive genetic counselling market size is expected to increase from USD 2.85 billion in 2024 to USD 8.43 billion by 2034.

The predictive genetic counselling market is expected to grow at a compound annual growth rate (CAGR) of around 11.45% from 2025 to 2034.

The major players in the predictive genetic counselling market include Myriad Genetics, Quest Diagnostics, Natera Inc., Ambry Genetics, Color Health, GeneDx (BioReference), Laboratory Corporation of America (LabCorp), Fulgent Genetics, Baylor Genetics, Sema4, Counsyl, Genome Medical, Genomic Health, 23andMe, PathGroup, MedGenome, Centogene AG, Veritas Genetics, Mapmygenome India, Segment Insights

The driving factors of the predictive genetic counselling market are the increasing awareness of genetic testing and preventive care. A growing number of individuals are opting for predictive screening to assess risks of cancers, cardiovascular conditions, and neurological disorders

North America region will lead the global predictive genetic counselling market during the forecast period 2025 to 2034.